Intra-Cellular Therapies ...

NASDAQ: ITCI · Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-74.68M -139.67M -256.26M -284.13M -227.01M -147.72M -155.13M -97.77M -116.43M
-8.52M 528K 656K 533.36K 528.12K 477.12K 368.67K 213.87K 196.87K
64.03M 52.83M 43.01M 34.3M 24.11M 20.79M 17.4M 14.64M 14.7M
-1.33M 34.54M 11.16M 740.84K -7.53M 5.95M 12.16M -1.04M 1.27M
82K -8.31M 537K 178.53K 214.1K 194.21K -529.97M 1.06B 233.77K
n/a n/a n/a -4.08M -648.25K -1.13M 529.22M -1.06B 544.35K
-54.1M -29.58M -58.14M -6.35M -27.28M -589.48K 19.94M 1.81M 9.49M
-73.18M -124.2M -270.19M -259.54M -230.07M -127.98M -118.17M -80.49M -91.26M
-322K -269K -778K -325.74K -266.72K -700.39K -391.27K -723.43K -48.96K
n/a n/a 127.59M -280.67M 480.03M -178.14M n/a n/a n/a
-739.68M -415.27M -759.21M -224.57M -755.63M -80.72M -271.16M -520.93M -395.76M
404.85M 521.08M 631.61M 505.24M 275.6M 258.86M 406.19M 428.93M 488.07M
n/a n/a -127.59M 280.67M -480.03M 178.14M 135.03M -91.99M 92.31M
-335.15M 105.54M -128.37M 280.34M -480.3M 177.44M 134.64M -92.72M 92.26M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
24.42M 17.81M 21.44M 11.52M 71.00 3.24M 685.19K 285.16K 477.73K
567.51M 17.81M 455.16M 11.52M 664.18M 3.24M 685.19K 162.36M 477.73K
159.18M -848K 56.6M 32.32M -46.19M 52.69M 17.16M -10.85M 1.48M
-73.5M -124.47M -270.96M -259.87M -230.34M -128.68M -118.56M -81.22M -91.31M